Clinical trials
Obesity trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
180 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 6 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 6 |
| 2020 | 5 |
| 2021 | 11 |
| 2022 | 6 |
| 2023 | 14 |
| 2024 | 15 |
| 2025 | 25 |
| 2026 | 34 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 86 |
| Recruiting | 35 |
| Unknown status | 18 |
| Not yet recruiting | 15 |
| Active, not recruiting | 15 |
| Terminated | 9 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 22 |
| Eli Lilly and Company | 13 |
| University of Adelaide | 9 |
| Amgen | 7 |
| Zafgen, Inc. | 7 |
| University of Melbourne | 6 |
| University of Sydney | 6 |
| AstraZeneca | 5 |
| Boehringer Ingelheim | 5 |
| Sanofi | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 180 |
| Overweight | 74 |
| Diabetes Mellitus, Type 2 | 27 |
| Cardiovascular Diseases | 9 |
| Insulin Resistance | 9 |
| Sleep Apnea, Obstructive | 9 |
| Weight Loss | 8 |
| Osteoarthritis, Knee | 6 |
| Diabetes Mellitus | 5 |
| Inflammation | 5 |
Trials
Showing 1 to 25 of 180. Each trial links to its page on Pharma Observatory.
80 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.